Loading Map....
Feb
9
2019
Upon completion of this course, participants should be able to:
- Review modern classification for resectable, borderline resectable and locally advanced pancreatic cancer.
- Discuss evidence and guideline basis for current management of localized and metastatic pancreatic cancer.
- Review active/upcoming clinical trials assessing novel chemotherapy and radiation strategies for pancreatic cancer.
Accreditations:
The University of Cincinnati is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. The University of Cincinnati designates this live activity for a maximum of 3.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. This CME activity is planned to meet the needs of practicing medical oncologists and other clinical and medical staff involved in the treatment of pancreatic cancer.
Register to Attend
Bookings are closed for this event.
